Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 22.06.2026 1 AJR Am J Roentgenol 1 Ann Surg 3 Ann Surg Oncol 2 BMC Cancer 2 Br J Cancer 7 Breast Cancer 1 Breast Cancer (Auckl) 4 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 3 Breast Cancer Res Treat 1 Breast J 1 Cancer 1 Cancer Cell 1 Cancer Res 7 Clin Breast Cancer 2 Eur J Cancer 5 Eur Radiol 1 Histopathology 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Natl Cancer Inst 1 Mod Pathol 1 Mol Ther Oncol 4 NPJ Breast Cancer 3 Oncogene 4 PLoS One 1 Proc Natl Acad Sci U S A 3 Radiol Artif Intell 1 Radiol Imaging Cancer 3 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. COFFEY K, Maimone S, Zamora K, Miller T, et al
   Isolated Axillary Lymphadenopathy in Women Without a Known Breast Cancer Diagnosis: A Multicenter Study of Biopsy Outcomes.
   AJR Am J Roentgenol. 2026 Jun 17. doi: 10.2214/AJR.26.34937.
   PubMed        
   
   

   
   Ann Surg

2. DEN J, Vaghjiani R, Hutter M, Klimberg VS, et al
   GLP-1 Receptor Agonists vs Bariatric Surgery in Breast Cancer: A Comparative Study of Oncologic Outcomes.
   Ann Surg. 2026 Jun 16. doi: 10.1097/SLA.0000000000007121.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. GERVAIS C, Brouillette K, Benzouak T, Altuntur SK, et al
   Impact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2026 Jun 18. doi: 10.1245/s10434-026-20013.
   PubMed         Abstract available
   
   
4. BAE SJ, Lee J, Do SI, Kim EY, et al
   Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.
   Ann Surg Oncol. 2026 Jun 15. doi: 10.1245/s10434-026-19966.
   PubMed         Abstract available
   
   
5. LEE JK, Alohaideb N, Pyon JK, Mun GH, et al
   Comprehensive Analysis of Full Coverage Versus Anterior Tenting Techniques for ADM Application in Prepectoral DTI Breast Reconstruction.
   Ann Surg Oncol. 2026;33:6839-6849.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. LIN LZ, Huang HY, Peng Y, Lin GQ, et al
   Preclinical evaluation of a fluorinated bifendate derivative in triple-negative breast cancer: integrated in vitro and in vivo evidence of antitumor activity.
   BMC Cancer. 2026 Jun 12. doi: 10.1186/s12885-026-16335.
   PubMed         Abstract available
   
   
7. SALHI I, Maqboul H, Jallad F, Jaradat H, et al
   Immunohistochemical breast cancer subtypes in Palestinian Women: an 18-year multicenter retrospective analysis.
   BMC Cancer. 2026 Jun 18. doi: 10.1186/s12885-026-16319.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. CHIRIKOVA E, Ronckers CM, Little MP, Quinn E, et al
   Breast cancer incidence and mortality in population studies of radiation exposure: systematic review and meta-analysis.
   Br J Cancer. 2026 Jun 16. doi: 10.1038/s41416-026-03503.
   PubMed         Abstract available
   
   
9. CHIN JH, Kim D, Lee HS, Jeon S, et al
   Adjuvant radiotherapy and skin cancer risk in breast cancer survivors: a nationwide cohort study in Korea.
   Br J Cancer. 2026 Jun 12. doi: 10.1038/s41416-026-03485.
   PubMed         Abstract available
   
   

   
   Breast Cancer

10. NARUSAWA E, Katayama A, Koibuchi Y, Takata D, et al
    Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancer.
    Breast Cancer. 2026 Jun 12. doi: 10.1007/s12282-026-01869.
    PubMed         Abstract available
    
    
11. SCHASCHINGER T, Niederegger T, Diatta F, Matar DY, et al
    Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients.
    Breast Cancer. 2026 Jun 12. doi: 10.1007/s12282-026-01875.
    PubMed         Abstract available
    
    
12. SASADA S, Kumamaru H, Kinukawa N, Iwamoto T, et al
    Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer.
    Breast Cancer. 2026 Jun 12. doi: 10.1007/s12282-026-01881.
    PubMed         Abstract available
    
    
13. ALTUNDAG O, Altundag K
    Methodological considerations in prognostic modeling for HER2-positive breast cancer with lung metastasis.
    Breast Cancer. 2026 Jun 16. doi: 10.1007/s12282-026-01885.
    PubMed        
    
    
14. RUAN Y, Harsanyi H, Warkentin MT, Yang H, et al
    Risk of developing subsequent primary breast cancer among non-breast cancer survivors: a retrospective cohort study.
    Breast Cancer. 2026 Jun 16. doi: 10.1007/s12282-026-01880.
    PubMed         Abstract available
    
    
15. IWATA H, Masuda N, Yamamoto Y, Fujisawa T, et al
    Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
    Breast Cancer. 2026 Jun 18. doi: 10.1007/s12282-026-01862.
    PubMed         Abstract available
    
    
16. XIONG LG, Tu XF, Zheng XP, Guo RN, et al
    Identifying breast cancer subtypes and exploring spatial expression patterns of the key subtype-specific gene based on pathological images, single-cell sequencing, and spatial transcriptomic data.
    Breast Cancer. 2026 Jun 18. doi: 10.1007/s12282-026-01883.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Auckl)

17. MAWLOOD IBRAHIM A, Khalid Abdulldah A, Oueslati A, Gargouri M, et al
    Self-Examination and Screening Barriers Associated With Breast Cancer Stages Among Patient Women in Baghdad, Iraq.
    Breast Cancer (Auckl). 2026;20:11782234261458541.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

18. 
    Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis [Retraction].
    Breast Cancer (Dove Med Press). 2026;18:631806.
    PubMed         Abstract available
    
    
19. CHEN G, Yin B, Khan M, Yang Y, et al
    Pan-Cancer Analysis of a Depression-Related Gene Signature Identifies an Immunosuppressive Tumor Microenvironment and Links to Immunotherapy Response in Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:578930.
    PubMed         Abstract available
    
    
20. SHI H, Feng Y, Guo T, Shou W, et al
    HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies.
    Breast Cancer (Dove Med Press). 2026;18:612951.
    PubMed         Abstract available
    
    
21. ZHOU C, Guo Y, Meng Z, Wan K, et al
    Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study.
    Breast Cancer (Dove Med Press). 2026;18:563533.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

22. GHANTA P, Verma AK, Lin CH, Charan M, et al
    Therapeutic targeting of RAGE/STAT3 signaling abrogates S100A7-driven breast tumorigenicity and immune suppression.
    Breast Cancer Res. 2026;28:112.
    PubMed         Abstract available
    
    
23. NAKAO K, Komura M, Inaguma S, Nagano A, et al
    Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer.
    Breast Cancer Res. 2026 Jun 14. doi: 10.1186/s13058-026-02326.
    PubMed         Abstract available
    
    
24. GUZ J, Urbanowska-Domanska O, Zarakowska E, Gackowski D, et al
    Changes in active DNA demethylation pathway components during neoadjuvant chemotherapy and their prognostic significance in breast cancer.
    Breast Cancer Res. 2026 Jun 18. doi: 10.1186/s13058-026-02314.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

25. OZAKI Y, Yoshida K, Ichikawa T, Kitagawa M, et al
    Extracellular vesicles in nipple discharge for breast cancer screening.
    Breast Cancer Res Treat. 2026;217:53.
    PubMed         Abstract available
    
    
26. GIVANT M, Fanning JE, Chen A, Lefevre A, et al
    Rediscovering the Ciucci pathway: in-vivo evidence of a palmar lymphatic channel.
    Breast Cancer Res Treat. 2026;217:52.
    PubMed         Abstract available
    
    
27. TALEB I, Witmeyer S, Huck C, Fournier M, et al
    Adenoid cystic carcinoma of the breast: a case series of 26 patients.
    Breast Cancer Res Treat. 2026;217:49.
    PubMed         Abstract available
    
    

    
    Breast J

28. SAMIEE R, Kharaghani M, Shahsavand A, Forghani S, et al
    Effectiveness and Safety of Hypofractionated Radiotherapy in Patients With Ductal Carcinoma In Situ (DCIS).
    Breast J. 2026;2026:e9456822.
    PubMed         Abstract available
    
    

    
    Cancer

29. LAWRENCE L
    First-line CDK4/6 inhibitors fail to improve overall survival in advanced breast cancer.
    Cancer. 2026;132:e70441.
    PubMed        
    
    

    
    Cancer Cell

30. FAN G, Jin J, Wang J, Xu J, et al
    Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways.
    Cancer Cell. 2026;44:1160-1178.
    PubMed         Abstract available
    
    

    
    Cancer Res

31. HOU X, Chen M, Guo X, Xie Y, et al
    The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment That Drives Tumor Radioresistance.
    Cancer Res. 2026;86:3005-3025.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

32. LI C, Li X, Xu Q, Zhao J, et al
    A Study on the Association Between Preventive Behaviors and Quality of Life in High-risk Populations for Postoperative Lymphedema Following Breast Cancer Surgery.
    Clin Breast Cancer. 2026;26:30-38.
    PubMed         Abstract available
    
    
33. LIM JK, Gibson AE, He J, Antonucci A, et al
    Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time - A TriNetX Database Study.
    Clin Breast Cancer. 2026;26:39-45.
    PubMed         Abstract available
    
    
34. FREEMAN M, Prawdzic Senkowska A, Chehade R, Compaore S, et al
    Prevalence and Prognostic Implications of Circulating Tumor Cells Among Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast Cancer.
    Clin Breast Cancer. 2026;26:24-29.
    PubMed         Abstract available
    
    
35. SEJKA M, Skandarajah A, Saunders C
    Despite Advances, Repeat Breast-Conserving Surgery Rates Persist: A 25-Year National Analysis of Breast-Conserving Surgery in Australia.
    Clin Breast Cancer. 2026;26:153-160.
    PubMed         Abstract available
    
    
36. FALIVENE S, Motta M, Loganadane G, De Sanctis R, et al
    Postmastectomy Radiotherapy With Immediate Implant Reconstruction: Treatment Fractionation, Implant Plane, and Clinical Outcomes.
    Clin Breast Cancer. 2026;26:77-82.
    PubMed         Abstract available
    
    
37. KUMAR H, Hu Y, Tahir M, Tozbikian G, et al
    Incidence, Clinicopathologic Features, and Follow-up Results of Invasive Ductal Carcinoma With Lobular-Like Growth Pattern.
    Clin Breast Cancer. 2026;26:25-31.
    PubMed         Abstract available
    
    
38. YANG C, Tang L, Zhang L, Karam I, et al
    Identifying Symptom Clusters for Acute Dermatitis-Exploratory Analysis of a Randomized Control Trial Comparing Mepitel Film and Standard of Care for the Prevention of Radiation Dermatitis.
    Clin Breast Cancer. 2026;26:3-24.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

39. LOUIS FM, der Voort AV, Egeler MD, Ramshorst MSV, et al
    Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.
    Eur J Cancer. 2026;244:116882.
    PubMed         Abstract available
    
    
40. DAUCCIA C, Franzoi MA, Saura C, Hlauschek D, et al
    Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial.
    Eur J Cancer. 2026;244:116880.
    PubMed         Abstract available
    
    

    
    Eur Radiol

41. BUYUKCERAN EU
    Letter to the Editor: Breast cancer risk prediction with artificial intelligence-statistical improvement versus clinical impact.
    Eur Radiol. 2026 Jun 19. doi: 10.1007/s00330-026-12694.
    PubMed        
    
    
42. KIANI I, Pourakbar N, Azizpour AM, Mousavi T, et al
    Assessing the performance of deep learning and hand-crafted radiomics models using MRI and ultrasound in predicting axillary lymph node status in breast cancer: a systematic review and meta-analysis.
    Eur Radiol. 2026 Jun 19. doi: 10.1007/s00330-026-12682.
    PubMed         Abstract available
    
    
43. TENDERO R, Larroza A, Perez-Benito FJ, Perez-Cortes JC, et al
    Reply to the Letter to the Editor: Breast cancer risk prediction with artificial intelligence-statistical improvement versus clinical impact.
    Eur Radiol. 2026 Jun 19. doi: 10.1007/s00330-026-12695.
    PubMed        
    
    
44. MARTINIUSSEN MA, Bergan MB, Kristiansen MU, Hoff SR, et al
    Location of AI risk markers and associated mammographic features in screening mammograms obtained years before screen-detected breast cancer.
    Eur Radiol. 2026 Jun 18. doi: 10.1007/s00330-026-12689.
    PubMed         Abstract available
    
    
45. CAMPS-HERRERO J, Gullo RL, Athanasiou A, Fuchsjaeger M, et al
    European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO.
    Eur Radiol. 2026 Jun 16. doi: 10.1007/s00330-026-12558.
    PubMed         Abstract available
    
    

    
    Histopathology

46. GROSSE C, Grosse A, Noack P, Preuss CI, et al
    Effects of short-course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor-positive, HER2-negative breast cancer.
    Histopathology. 2026 Jun 18. doi: 10.1111/his.70203.
    PubMed         Abstract available
    
    

    
    Int J Cancer

47. LE YANG R, Liang Y
    Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.
    Int J Cancer. 2026 Jun 14. doi: 10.1002/ijc.70607.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

48. ALATI A, Debbi K, Scher N, Meynard C, et al
    Multicenter Retrospective Analysis of the Safety and Efficacy of Sacituzumab Govitecan Combined With Radiation Therapy: The French ATTENTION Study.
    Int J Radiat Oncol Biol Phys. 2026;125:755-762.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

49. WANG X, Xu X, Li Y
    RE: Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
    J Natl Cancer Inst. 2026 Jun 12:djag188. doi: 10.1093.
    PubMed        
    
    

    
    Mod Pathol

50. YU S, Dekker M, Zwager MC, Slagter-Menkema L, et al
    Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis.
    Mod Pathol. 2026;39:101004.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncol

51. JO S, Shim WC, Park S, Kweon T, et al
    Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.
    Mol Ther Oncol. 2026;34:201242.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

52. WANDER SA, Weipert CM, Cabel L, Liao J, et al
    Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer.
    NPJ Breast Cancer. 2026 Jun 12. doi: 10.1038/s41523-026-00986.
    PubMed         Abstract available
    
    
53. CYBULSKI C, Kluzniak W, Wokolorczyk D, Zamani N, et al
    PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer.
    NPJ Breast Cancer. 2026 Jun 15. doi: 10.1038/s41523-026-00992.
    PubMed         Abstract available
    
    
54. MONSERRAT L, Garcia-Garcia J, Molina C, Odena A, et al
    Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer.
    NPJ Breast Cancer. 2026 Jun 17. doi: 10.1038/s41523-026-00993.
    PubMed         Abstract available
    
    
55. YU Y, Xu Z, Zhu Z, Liao J, et al
    Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning.
    NPJ Breast Cancer. 2026 Jun 17. doi: 10.1038/s41523-026-00991.
    PubMed         Abstract available
    
    

    
    Oncogene

56. SEIJO-VILA M, Balsinde SA, Blasco-Benito S, Tundidor I, et al
    Cannabinoid CB(2) receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
    Oncogene. 2026;45:2436-2451.
    PubMed         Abstract available
    
    
57. YANG Q, Ding H, Chen L, Sun S, et al
    A feedback mechanism between E3 ligase RNF122 and HIF-1alpha inhibits aggressive behavior in breast cancer.
    Oncogene. 2026 Jun 17. doi: 10.1038/s41388-026-03853.
    PubMed         Abstract available
    
    
58. LI Q, Fan M, Sun X, Yang X, et al
    LCAL4-FUS cooperation switches on MMP13 and drives osteolytic bone metastasis in breast cancer.
    Oncogene. 2026 Jun 18. doi: 10.1038/s41388-026-03848.
    PubMed         Abstract available
    
    

    
    PLoS One

59. KHALIFA M, Soliman M, Omar A, Abouegylah M, et al
    Thyroid V40 as a potential early predictor of hypothyroidism following hypofractionated locoregional breast radiotherapy.
    PLoS One. 2026;21:e0351856.
    PubMed         Abstract available
    
    
60. ZHENG LW, Liu YM, Yu KD, Liu CC, et al
    A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer.
    PLoS One. 2026;21:e0349410.
    PubMed         Abstract available
    
    
61. KOUAME JM, Kouakou C, Gnanou S, Yacouba B, et al
    Markov modeling in R: Advanced method using a cost-effectiveness analysis.
    PLoS One. 2026;21:e0350698.
    PubMed         Abstract available
    
    
62. NDUKA IJ, Okafor CE, Ekwunife OI
    Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria.
    PLoS One. 2026;21:e0351492.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

63. MISHRA A, Abelman RO, Cunneely Q, Putaturo V, et al
    Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.
    Proc Natl Acad Sci U S A. 2026;123:e2601563123.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

64. MOSHINA N, Larsen M, Holen AS, Aase HS, et al
    Artificial Intelligence for Digital Breast Tomosynthesis Screening with and without Prior Examinations in BreastScreen Norway.
    Radiol Artif Intell. 2026;8:e250988.
    PubMed         Abstract available
    
    
65. TOURASSE C, Mesurolle B, Ottavy M, Soler-Michel P, et al
    AI as a Safety Net Reader for Mammograms Classified as Normal or Benign in the French Screening Program.
    Radiol Artif Intell. 2026;8:e250989.
    PubMed         Abstract available
    
    
66. YAO MS, Chae A
    Artificial Intelligence as a Triage Partner in Breast Cancer Screening.
    Radiol Artif Intell. 2026;8:e260493.
    PubMed        
    
    

    
    Radiol Imaging Cancer

67. JEON S, Yoon J, Nguyen THT, Chang Y, et al
    Longitudinal Mammographic Breast Density Changes and Associated Factors in Older Korean Women.
    Radiol Imaging Cancer. 2026;8:e250332.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

68. CHAKRABORTY S, Chatterjee S, S P, Lal P, et al
    Impact of ultrahypofractionated adjuvant regional nodal radiotherapy on patient-reported quality of life: the HYPORT adjuvant trial (NCT03788213).
    Radiother Oncol. 2026;220:111576.
    PubMed         Abstract available
    
    
69. SHAITELMAN SF, Krishnamurthy S, Rauch GM, Lin H, et al
    Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial.
    Radiother Oncol. 2026;220:111573.
    PubMed         Abstract available
    
    
70. LEMANSKI C, Houvenaeghel G, Gourgou S, Gutowski M, et al
    Feasibility and safety of repeat breast-conserving surgery with intraoperative irradiation for local breast carcinoma recurrences: A phase 2 trial.
    Radiother Oncol. 2026;220:111538.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum